Is rimonabant a safe and effective therapy for sustained weight loss and improved cardiometabolic risk factors?
- PMID: 16810170
- DOI: 10.1038/ncpcardio0598
Is rimonabant a safe and effective therapy for sustained weight loss and improved cardiometabolic risk factors?
Erratum in
- Nat Clin Pract Cardiovasc Med. 2006 Sep;3(9):520
Comment on
-
Effect of rimonabant, a cannabinoid-1 receptor blocker, on weight and cardiometabolic risk factors in overweight or obese patients: RIO-North America: a randomized controlled trial.JAMA. 2006 Feb 15;295(7):761-75. doi: 10.1001/jama.295.7.761. JAMA. 2006. PMID: 16478899 Clinical Trial.
Publication types
LinkOut - more resources
Full Text Sources